MBRX - .7702 Moleculin Biotech Issues Shareholder Update on FDA Designation of Orphan Drug and IND Status for Annamycin http://stockcharts.com/c-sc/sc?s=MBRX&p=D&b=5&g=0&i=t32249277179&r=1495542921467 http://stockcharts.com/c-sc/sc?s=MBRX&p=W&b=5&g=0&i=t10386617508&r=1495542901998